Trending Stock News

Gran Tierra Energy Inc. (GTE) EPS Estimated At $0.11; Introgen Therapeutics (INGN) Has 1.18 Sentiment

Inogen, Inc. (NASDAQ:INGN) Logo

Introgen Therapeutics Inc (INGN) investors sentiment decreased to 1.18 in 2017 Q4. It’s down -0.02, from 1.2 in 2017Q3. The ratio fall, as 103 investment professionals started new and increased holdings, while 87 reduced and sold their equity positions in Introgen Therapeutics Inc. The investment professionals in our database now own: 20.27 million shares, down from 20.61 million shares in 2017Q3. Also, the number of investment professionals holding Introgen Therapeutics Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 19 Reduced: 68 Increased: 66 New Position: 37.

Analysts expect Gran Tierra Energy Inc. (TSE:GTE) to report $0.11 EPS on May, 2.They anticipate $0.07 EPS change or 175.00% from last quarter’s $0.04 EPS. T_GTE’s profit would be $44.67M giving it 8.64 P/E if the $0.11 EPS is correct. After having $0.05 EPS previously, Gran Tierra Energy Inc.’s analysts see 120.00% EPS growth. The stock increased 0.53% or $0.02 during the last trading session, reaching $3.8. About 14,100 shares traded. Gran Tierra Energy Inc. (TSE:GTE) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

The stock increased 0.80% or $1.11 during the last trading session, reaching $140.54. About 15,444 shares traded. Inogen, Inc. (INGN) has risen 59.63% since April 17, 2017 and is uptrending. It has outperformed by 48.08% the S&P500.

Analysts await Inogen, Inc. (NASDAQ:INGN) to report earnings on May, 8. They expect $0.27 earnings per share, 0.00% or $0.00 from last year’s $0.27 per share. INGN’s profit will be $5.73M for 130.13 P/E if the $0.27 EPS becomes a reality. After $0.31 actual earnings per share reported by Inogen, Inc. for the previous quarter, Wall Street now forecasts -12.90% negative EPS growth.

Inogen, Inc., a medical technology company, primarily develops, makes, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company has market cap of $2.98 billion. The companyÂ’s oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It has a 146.4 P/E ratio. It offers Inogen One systems, which are portable devices that concentrate the air around the patients to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories.

Brown Capital Management Llc holds 3.27% of its portfolio in Inogen, Inc. for 2.26 million shares. Tirschwell & Loewy Inc owns 164,055 shares or 2.76% of their US portfolio. Moreover, Oberweis Asset Management Inc has 1.4% invested in the company for 50,320 shares. The Wisconsin-based Cortina Asset Management Llc has invested 1.12% in the stock. Timpani Capital Management Llc, a Wisconsin-based fund reported 25,688 shares.

Inogen, Inc. (NASDAQ:INGN) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *